mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2011-671mrj-356Research ArticleСтатьиArticlesЭторикоксиб (аркоксиа) в ревматологииEtoricoxib (arcoxia) in rheumatologyКудаеваФ. М.KudaevaFatima Magomedovnakufat@rambler.ruБарсковаВ. Г.BarskovaV G-KudayevaFatima MagomedovnaKudayevaFatima Magomedovnakufat@rambler.ruБарсковаВ. Г.BarskovaV G-20111406201152№2 (2011)6164Copyright © Кудаева Ф.М., Барскова В.Г., Kudayeva F.M., Барскова В.Г., 20112011Кудаева Ф.М., Барскова В.Г., Kudayeva F.M., Барскова В.Г.Kudaeva F.M., Barskova V.G., Kudayeva F.M., Barskova V.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/356

В статье представлена информация о селективном ингибиторе ЦОГ 2 эторикоксибе, зарегистрированном для применения во многих странах мира. Дано краткое описание некоторых ключевых исследований, посвященных эффективности и переносимости эторикоксиба в ревматологии.

The paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatology

нестероидные противовоспалительные препаратыревматические заболеванияэторикоксибnonsteroidal anti-inflammatory drugsrheumatic diseasesetoricoxibReferences<div><p>Patrignani P., Capone M., Tacconelli S. Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. Expert Opin Pharmacother 2003; 4(2): 265-84.</p><p>Martina S., Vesta K., Ripley T. Etoricoxib: a highly selective COX-2 inhibitor. Ann Pharmacother 2005; 39(5): 854-62.</p><p>Brooks P., Kubler P. Etoricoxib for arthritis and pain management. Ther Clin Risk Manag 2006; 2(1): 45-57.</p><p>Zacher J., Feldman D., Gerli R. et al. A comparison of the therapeutic efficacy and tolerability of Etoricoxib and Diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003; 19(8): 725-36.</p><p>Wiesenhutter C.W., Boice J.A., Ko A. et al. A comparison of the therapeutic efficacy of Etoricoxib and Ibuprofen in patients with osteoarthritis: randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005; 80: 470-9.</p><p>Collantes E., Curtis S.P., Lee K.W. et al. International randomized controlled study of etoricoxib in rheumatoid arthritis. BMC Fam Pract 2002; 3: 10.</p><p>Van der Heijde D., Baraf H., Ramos-Remus C. et al. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthr Rheum 2005; 52(4): 1205-15.</p><p>Schumacher H., Boice J., Dahikh D. et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002; 324: 1488-92.</p><p>Pallay R.M., Seger W., Adler J.L. et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33: 257-66.</p><p>Birbara C.A., Puopolo A.D., Munoz D.R. et al. Treatment of chronic low back pain with etoricoxib, a new cyclooxygenase-2 selective inhibitor: improvement in pain and disability - a randomized, placebo-controlled, 3-month trial. J Pain 2003; 4: 307-15.</p><p>Boonriong T., Tangtrakulwanich B., Glablay P. et al. Comparing Etoricoxib and Celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial. BMC Musculoskeletal Dis 2010; 11: 246.</p><p>Siddiqui A., Sadat-Ali M., Al-Ghamdi A. et al. The effect of etoricoxib premedication on postoperative analgesia requirement in orthopedic and trauma patients. Saudi Med J 2008; 29(7): 966-70.</p></div><br /><div><p>Patrignani P., Capone M., Tacconelli S. Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor. Expert Opin Pharmacother 2003; 4(2): 265-84.</p><p>Martina S., Vesta K., Ripley T. Etoricoxib: a highly selective COX-2 inhibitor. Ann Pharmacother 2005; 39(5): 854-62.</p><p>Brooks P., Kubler P. Etoricoxib for arthritis and pain management. Ther Clin Risk Manag 2006; 2(1): 45-57.</p><p>Zacher J., Feldman D., Gerli R. et al. A comparison of the therapeutic efficacy and tolerability of Etoricoxib and Diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003; 19(8): 725-36.</p><p>Wiesenhutter C.W., Boice J.A., Ko A. et al. A comparison of the therapeutic efficacy of Etoricoxib and Ibuprofen in patients with osteoarthritis: randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005; 80: 470-9.</p><p>Collantes E., Curtis S.P., Lee K.W. et al. International randomized controlled study of etoricoxib in rheumatoid arthritis. BMC Fam Pract 2002; 3: 10.</p><p>Van der Heijde D., Baraf H., Ramos-Remus C. et al. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthr Rheum 2005; 52(4): 1205-15.</p><p>Schumacher H., Boice J., Dahikh D. et al. Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002; 324: 1488-92.</p><p>Pallay R.M., Seger W., Adler J.L. et al. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Scand J Rheumatol 2004; 33: 257-66.</p><p>Birbara C.A., Puopolo A.D., Munoz D.R. et al. Treatment of chronic low back pain with etoricoxib, a new cyclooxygenase-2 selective inhibitor: improvement in pain and disability - a randomized, placebo-controlled, 3-month trial. J Pain 2003; 4: 307-15.</p><p>Boonriong T., Tangtrakulwanich B., Glablay P. et al. Comparing Etoricoxib and Celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial. BMC Musculoskeletal Dis 2010; 11: 246.</p><p>Siddiqui A., Sadat-Ali M., Al-Ghamdi A. et al. The effect of etoricoxib premedication on postoperative analgesia requirement in orthopedic and trauma patients. Saudi Med J 2008; 29(7): 966-70.</p></div><br />

The authors declare that there are no conflicts of interest present.